Our Investment Approach
We are building a network of universities, entrepreneurs, foundations, angel investors, early-stage investors, and pharmaceutical and biotech companies. We work with all stakeholders to meet our goals.
We are active managers in our investments. We leverage the experience and expertise of our team and advisors to work closely with our investments and to enable their growth and success.
Our team and advisors havicone deep biomedical industry knowledge, including bringing scores of drugs and medical products to market, running clinical trials, and founding and growing new businesses.
Our investments include traditional product start-ups and platform technology companies, as well as project financing for single assets. We have identified projects ready for investment right now from $250,000 to $5 million. Donate and we can put your money to work right now.
Michele Kong, MD
Scientific Advisory Board (under formation)
Dan Smith, PhD
Business Advisory Board (under formation)